Descriptive analysis of molecular subtypes in Tunisian breast cancer

Asia-Pacific Journal of Clinical Oncology

Volumn 10, Issue 2, 2014, Pages

  Fourati, Asma ^a,c   Boussen, Hamouda ^b   El May, Michéle V ^c   Goucha, Aida ^a   Dabbabi, Bouthaina ^c   Gamoudi, Amor ^a   Sfar, Rachida ^a   Rahal, Khaled ^a   El May, Ahmed ^a,c   Ben Abdallah, Mansour ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^c UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Breast cancer; Hormone receptor; Human epidermal growth factor receptor 2; Immunohistochemistry; Molecular subtype

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SIZE; ETHNIC GROUP; FEMALE; FOLLOW UP; GROUPS BY AGE; HER2+ BREAST CANCER; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER; TUNISIAN; AGE; BREAST NEOPLASMS; CANCER STAGING; CLASSIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUNISIA;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TRIPLE NEGATIVE BREAST NEOPLASMS; TUNISIA;

EID: 84901613351     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12034     Document Type: Article

References (31)

1. Boussen H, Bouzaiene H, Ben Hassouna J etal. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Cancer 2010; 116: 2730-2735.
2. Ben Abdallah M, Zehani S, Maalej M etal. Breast cancer in Tunisia: epidemiologic characteristics and trends in incidence. Tunis Med 2009; 87: 417-425.
3. van't Veer LJ, Dai H, van de Vijver MJ etal. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
4. Sorlie T, Tibshirani R, Parker J etal. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100: 8418-8423.
5. Sotiriou C, Neo SY, McShane LM etal. Breast classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003; 100: 10393-10398.
6. Wiencke JK. Opinion: impact of race ethnicity on molecular pathways in human cancer. Nat Rev Cancer 2004; 4: 79-84.
7. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
8. Golub TR, Slonim DK, Tamayo P etal. Molecular classification of cancer: class discovery and class prediction by gene expression monitorind. Science 1999; 286: 531-537.
9. Perou CM, Sørlie T, Eisen MB etal. Molecular portraits of human breast tumors. Nature 2000; 406: 747-752.
10. Simon R, Ramacher MD, Dobbin K. Design of studies using DNA microarrays. Genet Epidemiol 2002; 23: 21-36.
11. Sørlie T, Perou CM, Tibshirani R etal. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.
12. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of oestrogen receptor (ER) negative, progesterone receptor (PR) negative and Her2-negative invasive breast cancer, the so-called triple negative phenotype: a population-based study from the California cancer registry. Cancer 2007; 109: 1721-1726.
13. Yu K, Lee CH, Tan PH, Tan P. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res 2004; 10: 5508-5517.
14. Nielsen TO, Hsu FD, Jensen K etal. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast cancer. Clin Cancer Res 2004; 10: 5367-5374.
15. Ben Abdelkrim S, Trabelsi A, Missaoui N etal. Distribution of molecular breast cancer subtypes among Tunisian women and correlation with histological parameters: a study of 194 patients. Pathol Res Pract 2010; 206: 772-775.
16. Salhia B, Tapia C, Ishak EA etal. Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favourable biology. BMC Womens Health 2011; 11: 4.
17. Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A. Breast cancer classification according to immunohistochemical markers: clinocopathologic features and short-term survival analysis in a population-based study from the south of Switzerland. Ann Oncol 2009; 20: 628-635.
18. Del Casar JM, Martín A, García C etal. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol 2008; 141: 147-152.
19. Su Y, Zheng Y, Zheng W etal. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC cancer 2011; 11: 292-299.
20. Carey LA, Perou CM, Livasy CA etal. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer study. JAMA 2006; 295: 2492-2502.
21. Newman LA. Breast cancer in African American women. Oncologist 2005; 10: 1-14.
22. Awadelkarim KD, Arizzi C, Elamin EO etal. Pathological, clinical and prognostic characteristics of breast cancer in central Sudan versus northern Italy: implications for breast cancer in Africa. Histopathology 2008; 52: 445-456.
23. Huo D, Ikpatt F, Khramtsov A etal. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-4521.
24. AlTamimi DM, Shawarby MA, Ahmed A, Hassen AK, Alodaini AA. Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study. Ultrastruct Pathol 2009; 33: 141-150.
25. Nakajima H, Fujiwara I, Mizuta N etal. Prognosis of Japanese breast cancer based on hormone receptor and Her-2 expression determined by immunohistochemical staining. World J Surg 2008; 32: 2477-2482.
26. Han W, Nicolau M, Noh DY, Jeffrey SS. Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population. Int J Oncol 2010; 1: 51-59.
27. Chlebowski RT, Chen Z, Anderson GL etal. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97: 439-448.
28. Zarcone M, Amodio R, Campisi I etal. Application of a new classification to a breast tumor series from a population-based cancer registry. Steroid Enzymes Cancer 2009; 1155: 222-226.
29. Calza S, Hall P, Auer G etal. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 2006; 8: R34.
30. Foulkes WD, Stefansson IM, Chappuis PO etal. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95: 1482-1485.
31. Tang P, Wang J, Bourne P. Molecular classifications of breast carcinomas with similar terminology and different definitions: are they the same? Hum Pathol 2008; 39: 506-513.